AstraZeneca announced Phase III HICKORY findings for investigational efzimfotase alfa in 124 treatment-naïve adolescents and adults with hypophosphatasia. At week 25, the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results